STD testing market faces hurdles amidst limited healthcare services

Existing stigmas also lead to avoidance of testing and untreated cases.

The global sexually transmitted disease (STD) testing market is projected to surge by $32.37b through 2028 at a compound annual growth rate of 5.6%. However, limited healthcare services in developing regions pose a burden to the sector.

A Technavio report revealed many individuals, particularly in Asia and the Middle East and Africa region, lack adequate knowledge about STDs and access to healthcare facilities, which contribute to high rates of HIV infection.

“Developing countries like Kenya, Algeria, Afghanistan, and Bangladesh face challenges in providing efficient healthcare services due to a lack of technology, infrastructure, and skilled healthcare professionals,” it said.

Moreover, stigmas, including misconceptions about HIV and embarrassment related to physical examinations, lead to avoidance of testing and untreated cases.

These factors are expected to hinder growth in the STD testing market in these regions, contributing to increased HIV prevalence and resulting in higher mortality and morbidity rates.